JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5176
CALL
Dell
DELL
$351B
| $101K | ﹤0.01% |
+2,500
| New | +$101K |
2023 Q1
0 quarters
|
|
|
5177
PUT
Dell
DELL
$351B
| $101K | ﹤0.01% |
+2,500
| New | +$101K |
2023 Q1
0 quarters
|
|
5178
WisdomTree Europe SmallCap Dividend Fund
DFE
$162M
| $101K | ﹤0.01% |
1,731
-200
| -10% | -$11.7K |
2014 Q2
35 quarters
|
|
5179
FT Vest US Equity Moderate Buffer ETF February
GFEB
$375M
| $101K | ﹤0.01% |
+3,412
| New | +$98.9K |
2023 Q1
0 quarters
|
|
5180
ProShares Bitcoin Strategy ETF
BITO
$1.73B
| $101K | ﹤0.01% |
5,752
| – | – |
2022 Q4
1 quarter
|
|
5181
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$350M
| $100K | ﹤0.01% |
3,226
+3,123
| +3,032% | +$96.6K |
2022 Q3
2 quarters
|
|
5182
Colliers International
CIGI
$4.55B
| $100K | ﹤0.01% |
943
| – | – |
2022 Q1
4 quarters
|
|
|
CMLS
5183
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $100K | ﹤0.01% |
27,300
+1,208
| +5% | +$6.79K |
2019 Q1
16 quarters
|
|
|
ICVX
5184
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $100K | ﹤0.01% |
17,165
+1,986
| +13% | +$17.2K |
2021 Q3
6 quarters
|
|
|
IHIT
5185
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
| $100K | ﹤0.01% |
12,807
+12,760
| +27,149% | +$103K |
2022 Q4
1 quarter
|
|
5186
WisdomTree Dynamic International SmallCap Equity Fund
DDLS
$417M
| $99.8K | ﹤0.01% |
3,161
+575
| +22% | +$18.2K |
2022 Q4
1 quarter
|
|
|
AKYA
5187
DELISTED
Akoya BioSciences
AKYA
| $99K | ﹤0.01% |
12,094
+3,154
| +35% | +$33K |
2021 Q2
7 quarters
|
|
5188
Bluerock Homes Trust
BHM
$32.9M
| $99K | ﹤0.01% |
5,201
-561
| -10% | -$11.5K |
2022 Q4
1 quarter
|
|
5189
Empire Petroleum
EP
$111M
| $99K | ﹤0.01% |
7,967
+138
| +2% | +$1.75K |
2022 Q2
3 quarters
|
|
5190
CALL
Relay Therapeutics
RLAY
$4.25B
| $99K | ﹤0.01% |
+6,000
| New | +$108K |
2023 Q1
0 quarters
|
|
5191
Tenaya Therapeutics
TNYA
$126M
| $99K | ﹤0.01% |
34,668
+17,351
| +100% | +$48.8K |
2021 Q3
6 quarters
|
|
|
VNET
5192
VNET Group
VNET
$1.55B
| $98K | ﹤0.01% |
30,364
+18,153
| +149% | +$88.8K |
2022 Q2
3 quarters
|
|
|
BNT
5193
Brookfield Wealth Solutions
BNT
$10.9B
| $98K | ﹤0.01% |
4,448
+521
| +13% | +$11.8K |
2021 Q2
7 quarters
|
|
5194
NatWest
NWG
$69.3B
| $97.2K | ﹤0.01% |
14,635
-31,376
| -68% | -$221K |
2014 Q2
35 quarters
|
|
5195
PUT
Williams-Sonoma
WSM
$28.1B
| $97K | ﹤0.01% |
1,600
-92,800
| -98% | -$5.79M |
2022 Q4
1 quarter
|
|
|
GRTS
5196
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $97K | ﹤0.01% |
35,176
+5,255
| +18% | +$15K |
2018 Q3
18 quarters
|
|
5197
Foghorn Therapeutics
FHTX
$119M
| $96K | ﹤0.01% |
15,500
+4,125
| +36% | +$27K |
2020 Q4
9 quarters
|
|
|
NREF
5198
NexPoint Real Estate Finance
NREF
$292M
| $96K | ﹤0.01% |
6,175
+1,607
| +35% | +$28.2K |
2021 Q1
8 quarters
|
|
|
RBOT
5199
DELISTED
Vicarious Surgical
RBOT
| $96K | ﹤0.01% |
1,415
+382
| +37% | +$29.7K |
2021 Q4
5 quarters
|
|
|
SDC
5200
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $96K | ﹤0.01% |
222,242
+178,412
| +407% | +$91.4K |
2019 Q3
14 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.